Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Tình hình hiện tại của ngành ung thư bề mặt phúc mạc ở Ấn Độ
Tóm tắt
Với sự chấp nhận ngày càng tăng của phẫu thuật cắt giảm khối u và hóa trị tại chỗ (HIPEC) như một liệu pháp điều trị có khả năng chữa khỏi cho các khối u ác tính bề mặt phúc mạc nguyên phát và thứ phát, ung thư bề mặt phúc mạc đã nổi lên như một chuyên ngành riêng biệt trong lĩnh vực ung thư phẫu thuật. Trong 10 năm qua, sự chấp nhận một cách tiếp cận khác biệt trong việc quản lý di căn phúc mạc đã gia tăng tại Ấn Độ. Trong khoảng thời gian này, hơn 1000 thủ thuật kết hợp đã được thực hiện trên cả nước và hầu hết các thành phố lớn đều có trung tâm cung cấp liệu pháp này. Các bác sĩ phẫu thuật Ấn Độ đã thành lập các nhóm hợp tác để thúc đẩy nghiên cứu và phát triển chuyên ngành này trên toàn quốc. Bài báo này cung cấp cái nhìn tổng quan chi tiết về các phương pháp thực hành hiện tại liên quan đến ung thư bề mặt phúc mạc tại đất nước và hướng đi tương lai.
Từ khóa
#ung thư bề mặt phúc mạc #hóa trị tại chỗ #điều trị #Ấn Độ #phẫu thuật cắt giảm khối u #di căn phúc mạcTài liệu tham khảo
Sarin R (2015) Global trends in specialist training, certification, and regulation of oncology practice and its implications for the developing world. J Cancer Res Ther 11:675–678
India State-Level Disease Burden Initiative Collaborators (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the global burden of disease study. Lancet 390:2437–2460
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol. 2018;19(10):1289–1306
National Cancer Registry Programme (2015) WWW page. URL: http://ncrpindia.org. Last Accessed 2018 Feb 27
Bhatt A, Goéré D (2016) Cytoreductive surgery plus HIPEC for peritoneal metastases from colorectal Cancer. Indian J Surg Oncol 7(2):177–187
Seshadri RA, Glehen O (2016) The role of Hyperthermic intraperitoneal chemotherapy in gastric Cancer. Indian J Surg Oncol 7(2):198–207
Bakrin N, Classe JM, Pomel C, Gouy S, Chene G, Glehen O (2014) Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. J Visc Surg 151:347–353. https://doi.org/10.1016/j.jviscsurg.2014.07.005
Bevan KE, Mohamed F, Moran BJ (2010) Pseudomyxoma peritonei. World J Gastrointest Oncol 2(1):44–50
Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42
Fujimura T, Yonemura Y, Fushida S et al (1990) Continuous hyperthermic intraperitoneal perfusion for the treatment of peritoneal dissemination in gastric cancer and subsequent second-look operation. Cancer 65(1):65–71
Yamaguchi A, Tsukioka Y, Fushida S, et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancer. Dis Colon Rectum
Koga S, Shimizu N, Maeta M, Hamazoe R, Izumi A (1983) Application of heat combined with antineoplastic agent administration in the treatment of cancer (with special reference to malignancy of the digestive system). Gan to Kagaku Ryoho 10:358–365
Sayag AC, Gilly FN, Carry PY, Perdrix JP, Panteix G, Brachet A, Banssillon V, Braillon G (1993) Intraoperative chemohyperthermia in the management of digestive cancers. A general review of literature. Oncology 50(5):333–337
Bhatt A, Mehta S, Seshadri RA, Sethna K, Zaveri S, Rajan F, Mahajan V, Singh S, Raj EH, Sugarbaker PH (2016) The initial Indian experience with Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol 7(2):160–165
Guidelines for import and manufacture of medical devices [Internet]. India. CDSCO. Available at: www.cdsco.nic.in/forms/ list.aspx?lid = 1580&Id = 1. Accessed 12 Nov 2018
Radhadevi N, Balamuralidhara V, Pramod Kumar TM, Ravi V (2012) Regulatory guidelines for medical devices in India: an overview. Asian J Pharm 6:10–17
Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5(4):219–228
Veronesi U, Stafyla V (2012) Grand challenges in surgical oncology. Front Oncol 2:127. Published 2012 Oct 2. https://doi.org/10.3389/fonc.2012.00127
Smeenk RM, Verwaal VJ, Zoetmulder FA (2007) Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 94:1408–1414. https://doi.org/10.1002/bjs.5863
Kusamura S, Baratti D, Deraco M (2012) Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 255(2):348–356. https://doi.org/10.1097/SLA.0b013e3182436c28
Li Y, Yu Y, Liu Y (2014) Report on the 9th international congress on peritoneal surface malignancies. Cancer Biol Med 11(4):281–284
ICRETT – UICChttps://www.uicc.org/sites/main/files/private/ICRETT_Programme_Guidelines.pdf
Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK, Sagar TG, Sebastian P, Sarin R, Shanta V, Sharma SC, Shukla S, Vijayakumar M, Vijaykumar DK, Aggarwal A, Purushotham A, Sullivan R (2014) Delivery of affordable and equitable cancer care in India. Lancet Oncol 15(6):e223–e233. https://doi.org/10.1016/S1470-2045(14)70117-2
Thakur J, Prinja S, Garg CC, Mendis S, Menabde N (2011) Social and economic implications of noncommunicable diseases in India. Indian J Community Med 36(suppl 1):S13–S22
Bhatt A, Prabhu R, Sethna K, Tharayil S, Kumar M (2017) The “homemade” HIPEC [33] machine—a cost-effective alternative in low-resource countries. Pleura and Peritoneum 2:163–170
Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G (2018) Ninety-day post-operative [34] morbidity and mortality using the National Cancer Institute’s com- Mon terminology criteria for adverse events better describe post- operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth 34:532–537
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456
Villeneuve L, Passot G, Glehen O et al (2017) The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis 12:37
Bhatt A, Mehta S, Ramakrishnan AS et al (2017) Setting up of the Indian HIPEC registry: a registry for Indian patients with peritoneal surface malignancies. Indian J Surg Oncol 8:527–532
Sugarbaker PH (2017) The seven best from PSOGI 2016. Ann Surg Oncol 24:870–874
Bhatt A, Mehta S, Zaveri S, Rajan F, Ray M, Sethna K, Katdare N et al (2018) Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperth. https://doi.org/10.1080/02656736.2018.1503345
Bhatt A, Sheshadri D, Chandan G, Ramaswamy V, Pandey J, Bhorkar N, Agrawal D, Mehta S (2017) Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: A preliminary five-year experience. J BUON 22(1):251–257
Bhatt A, George A, Mehta S (2017) CRS and HIPEC for PMP-Use of the LC-CUSUM to Determine the Number of Procedures Required to Attain a Minimal Level of Proficiency in Delivering the Combined Modality Treatment. Indian J Surg Oncol 8(4):533–539. https://doi.org/10.1007/s13193-017-0692-8
Gupta N, Asif S, Gandhi J, Rajpurohit S, Singh S (2017) Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. Indian J Gastroenterol 36:126–130
Somashekhar SP, Prasanna G, Jaka R, Rauthan A, Murthy HS, Karanth S (2016) Hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a single institution Indian experience. Natl Med J India 29(5):262–266
Bhatt A, Mishra S, Prabhu R, Ramaswamy V, George A, Bhandare S, Shah M, Mehta S (2018) Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification. Eur J Surg Oncol 44(7):1105–1111. https://doi.org/10.1016/j.ejso.2018.03.032
Bhatt A, Sinukumar S, Zaveri S, Rajan F, Damodaran D, Kammar P, Mehta S (2018) A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer- A study by INDEPSO. Pleura and Peritoneum 2018; 1, Special Suppl, pp sA6–sA463. https://doi.org/10.1515/pap-2018-7013
Pramesh CS, Badwe RA, Sinha RK (2014) The National Cancer Grid of India. Indian J Med Paediatr Oncol 35:226–227
Katdare N, Prabhu R, Mishra S et al (2018) Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Initial Experience from Indian Centers and a Review of Literature. Indian J Surg Oncol. https://doi.org/10.1007/s13193-018-0771-5
Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D, French Surgical Association (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116(24):5608–5618. https://doi.org/10.1002/cncr.25356
Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M, Peritoneal Surface Oncology Group International (PSOGI) (2014) Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg 101(13):1758–1765. https://doi.org/10.1002/bjs.9674